HbA1c News and Research

RSS
Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

New legislation will increase access to health care, says DDI

New legislation will increase access to health care, says DDI

ChemoCentryx undertakes Phase II clinical trial of CCX140

ChemoCentryx undertakes Phase II clinical trial of CCX140

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

CoreObjects receives PMI Excellence Award for developing HbA1c Blood Sugar Analysis device

CoreObjects receives PMI Excellence Award for developing HbA1c Blood Sugar Analysis device

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Texas Health Dallas offers heart and vascular screening program for women

Texas Health Dallas offers heart and vascular screening program for women

Tubing-Free Insulin Pump System improves glycemic control in diabetic patients

Tubing-Free Insulin Pump System improves glycemic control in diabetic patients

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reports consolidated group sales of €1,032.8M for 2009

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

Evidence suggests insulin pumps may help in maintaining blood glucose levels in type 1 diabetic patients

OSA adversely affects glucose control in patients with type 2 diabetes

OSA adversely affects glucose control in patients with type 2 diabetes

American Clinical Laboratory Association lauds ADA's recommendation of HbA1C test for diabetes

American Clinical Laboratory Association lauds ADA's recommendation of HbA1C test for diabetes

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring